--> JCMarketResearch | Leading Market Research Company

Global Live Vaccines Market 2021 And Forecast 2029

Key Companies : Merck GlaxoSmithKline Pfizer Novartis Astellas Pharma Emergent BioSolutions AstraZeneca Market by Type : Monovalent Live Vaccines Multivalent Live Vaccines Market by Application : Adults Children By Region : Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland North America : United States, Canada, Mexico Middle East & Africa : GCC, North Africa, South Africa South America : Brazil, Argentina, Columbia, Chile, Peru

Chapter 1 Global Live Vaccines Market Overview 1.1 Introduction 1.2 Taxonomy 1.2.1 By Product Type & End User 1.2.2 By Region 1.3 Drivers for Live Vaccines Market 1.4 Restraints for Live Vaccines Market 1.5 Opportunities for Live Vaccines Market 1.6 Trends for Live Vaccines Market 1.7 COVID-19 Impact Assessment on Live Vaccines Industry 1.8 Macro-economic Factors 1.9 Regulatory Framework 1.10 Pricing Analysis by Region, 2020 1.11 Opportunity Map Analysis 1.12 Opportunity Orbits 1.13 Market Investment Feasibility Index 1.14 PEST Analysis 1.15 PORTERS Five Force Analysis 1.16 Go to Market Strategy 1.17 Value Chain Analysis 1.18 Cost Structure Analysis 1.19 Regional Market Share and BPS Analysis Chapter 2 Global Live Vaccines Market Overview 2.1 Global Live Vaccines Market by Product Type 2.1.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 2.1.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 2.1.3 Global Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 2.2 Global Live Vaccines Market by End User 2.2.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 2.2.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 2.2.3 Global Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 2.3 Global Live Vaccines Market by Region 2.3.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 2.3.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 2.3.3 Global Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 2.4 Global Live Vaccines Market Outlook (2013-2029) 2.4.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 2.4.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 2.5 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 2.5.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 2.5.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 2.6 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 2.6.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 2.6.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 2.7 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 2.7.1 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 2.7.2 Global Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 2.8 Global Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 2.8.1 Global Live Vaccines Market Y-o-Y Growth Rate by Region 2.8.2 Global Live Vaccines Market Y-o-Y Growth Rate by Product Type 2.8.3 Global Live Vaccines Market Y-o-Y Growth Rate by End User 2.9 Global Live Vaccines Market Share Comparison (2013-2029) 2.9.1 Global Live Vaccines Market Share by Region 2.9.2 Global Live Vaccines Market Share by Product Type 2.9.3 Global Live Vaccines Market Share by End User Chapter 3 North America Live Vaccines Market Overview 3.1 North America Live Vaccines Market by Product Type 3.1.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 3.1.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 3.1.3 North America Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 3.2 North America Live Vaccines Market by End User 3.2.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 3.2.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 3.2.3 North America Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 3.3 North America Live Vaccines Market by Region 3.3.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 3.3.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 3.3.3 North America Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 3.4 North America Live Vaccines Market Outlook (2013-2029) 3.4.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 3.4.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 3.5 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 3.5.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 3.5.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 3.6 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 3.6.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 3.6.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 3.7 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 3.7.1 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 3.7.2 North America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 3.8 North America Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 3.8.1 North America Live Vaccines Market Y-o-Y Growth Rate by Region 3.8.2 North America Live Vaccines Market Y-o-Y Growth Rate by Product Type 3.8.3 North America Live Vaccines Market Y-o-Y Growth Rate by End User 3.9 North America Live Vaccines Market Share Comparison (2013-2029) 3.9.1 North America Live Vaccines Market Share by Region 3.9.2 North America Live Vaccines Market Share by Product Type 3.9.3 North America Live Vaccines Market Share by End User Chapter 4 Europe Live Vaccines Market Overview 4.1 Europe Live Vaccines Market by Product Type 4.1.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 4.1.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 4.1.3 Europe Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 4.2 Europe Live Vaccines Market by End User 4.2.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 4.2.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 4.2.3 Europe Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 4.3 Europe Live Vaccines Market by Region 4.3.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 4.3.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 4.3.3 Europe Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 4.4 Europe Live Vaccines Market Outlook (2013-2029) 4.4.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 4.4.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 4.5 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 4.5.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 4.5.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 4.6 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 4.6.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 4.6.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 4.7 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 4.7.1 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 4.7.2 Europe Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 4.8 Europe Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 4.8.1 Europe Live Vaccines Market Y-o-Y Growth Rate by Region 4.8.2 Europe Live Vaccines Market Y-o-Y Growth Rate by Product Type 4.8.3 Europe Live Vaccines Market Y-o-Y Growth Rate by End User 4.9 Europe Live Vaccines Market Share Comparison (2013-2029) 4.9.1 Europe Live Vaccines Market Share by Region 4.9.2 Europe Live Vaccines Market Share by Product Type 4.9.3 Europe Live Vaccines Market Share by End User Chapter 5 Asia Pacific Live Vaccines Market Overview 5.1 Asia Pacific Live Vaccines Market by Product Type 5.1.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 5.1.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 5.1.3 Asia Pacific Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 5.2 Asia Pacific Live Vaccines Market by End User 5.2.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 5.2.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 5.2.3 Asia Pacific Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 5.3 Asia Pacific Live Vaccines Market by Region 5.3.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 5.3.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 5.3.3 Asia Pacific Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 5.4 Asia Pacific Live Vaccines Market Outlook (2013-2029) 5.4.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 5.4.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 5.5 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 5.5.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 5.5.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 5.6 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 5.6.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 5.6.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 5.7 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 5.7.1 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 5.7.2 Asia Pacific Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 5.8 Asia Pacific Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 5.8.1 Asia Pacific Live Vaccines Market Y-o-Y Growth Rate by Region 5.8.2 Asia Pacific Live Vaccines Market Y-o-Y Growth Rate by Product Type 5.8.3 Asia Pacific Live Vaccines Market Y-o-Y Growth Rate by End User 5.9 Asia Pacific Live Vaccines Market Share Comparison (2013-2029) 5.9.1 Asia Pacific Live Vaccines Market Share by Region 5.9.2 Asia Pacific Live Vaccines Market Share by Product Type 5.9.3 Asia Pacific Live Vaccines Market Share by End User Chapter 6 South America Live Vaccines Market Overview 6.1 South America Live Vaccines Market by Product Type 6.1.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 6.1.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 6.1.3 South America Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 6.2 South America Live Vaccines Market by End User 6.2.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 6.2.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 6.2.3 South America Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 6.3 South America Live Vaccines Market by Region 6.3.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 6.3.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 6.3.3 South America Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 6.4 South America Live Vaccines Market Outlook (2013-2029) 6.4.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 6.4.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 6.5 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 6.5.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 6.5.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 6.6 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 6.6.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 6.6.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 6.7 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 6.7.1 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 6.7.2 South America Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 6.8 South America Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 6.8.1 South America Live Vaccines Market Y-o-Y Growth Rate by Region 6.8.2 South America Live Vaccines Market Y-o-Y Growth Rate by Product Type 6.8.3 South America Live Vaccines Market Y-o-Y Growth Rate by End User 6.9 South America Live Vaccines Market Share Comparison 2013-2029 6.9.1 South America Live Vaccines Market Share by Region 6.9.2 South America Live Vaccines Market Share by Product Type 6.9.3 South America Live Vaccines Market Share by End User Chapter 7 MEA Live Vaccines Market Overview 7.1 MEA Live Vaccines Market by Product Type 7.1.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029) 7.1.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019 7.1.3 MEA Live Vaccines Market Attractiveness Analysis by Product Type, (2013-2020) 7.2 MEA Live Vaccines Market by End User 7.2.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029) 7.2.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019 7.2.3 MEA Live Vaccines Market Attractiveness Analysis by End User, (2013-2020) 7.3 MEA Live Vaccines Market by Region 7.3.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029) 7.3.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019 7.3.3 MEA Live Vaccines Market Attractiveness Analysis by Region, (2013-2020) 7.4 MEA Live Vaccines Market Outlook (2013-2029) 7.4.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) (2013-2020) 7.4.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) (2021-2029) 7.5 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) by Regions 7.5.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020) 7.5.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029) 7.6 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) by Product Type 7.6.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020) 7.6.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029) 7.7 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) by End User 7.7.1 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020) 7.7.2 MEA Live Vaccines Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029) 7.8 MEA Live Vaccines Market Y-o-Y Growth Rate Comparison (2014-2029) 7.8.1 MEA Live Vaccines Market Y-o-Y Growth Rate by Region 7.8.2 MEA Live Vaccines Market Y-o-Y Growth Rate by Product Type 7.8.3 MEA Live Vaccines Market Y-o-Y Growth Rate by End User 7.9 MEA Live Vaccines Market Share Comparison (2013-2029) 7.9.1 MEA Live Vaccines Market Share by Region 7.9.2 MEA Live Vaccines Market Share by Product Type 7.9.3 MEA Live Vaccines Market Share by End User Chapter 8 Global Live Vaccines Market Company Profiles 8.1 Market Competition Scenario Analysis, By Company 8.2 Competitor Landscape 8.3 Company Share Analysis 8.4 Company Profiles 8.4.1 Company 8.4.1.1 Company Overview 8.4.1.2 Business Description 8.4.1.3 Product Portfolio 8.4.1.4 Key Financials 8.4.1.5 Key Developments 8.4.1.6 SWOT Analysis Companies Included : Merck GlaxoSmithKline Pfizer Novartis Astellas Pharma Emergent BioSolutions AstraZeneca Chapter 9 Methodology and Data Source 9.1 Research Approach/ Methodology 9.2 Market Size Estimation 9.3 Market Breakdown and Data Triangulation 9.4 Data Source 9.4.1 Secondary Sources 9.4.2 Primary Sources
1126

5118

4164

OUR CLIENT